These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

192 related items for PubMed ID: 9667966

  • 1. Antihyperglycemic activities of cryptolepine analogues: an ethnobotanical lead structure isolated from Cryptolepis sanguinolenta.
    Bierer DE, Dubenko LG, Zhang P, Lu Q, Imbach PA, Garofalo AW, Phuan PW, Fort DM, Litvak J, Gerber RE, Sloan B, Luo J, Cooper R, Reaven GM.
    J Med Chem; 1998 Jul 16; 41(15):2754-64. PubMed ID: 9667966
    [Abstract] [Full Text] [Related]

  • 2. Ethnobotanical-directed discovery of the antihyperglycemic properties of cryptolepine: its isolation from Cryptolepis sanguinolenta, synthesis, and in vitro and in vivo activities.
    Bierer DE, Fort DM, Mendez CD, Luo J, Imbach PA, Dubenko LG, Jolad SD, Gerber RE, Litvak J, Lu Q, Zhang P, Reed MJ, Waldeck N, Bruening RC, Noamesi BK, Hector RF, Carlson TJ, King SR.
    J Med Chem; 1998 Mar 12; 41(6):894-901. PubMed ID: 9526563
    [Abstract] [Full Text] [Related]

  • 3. Cryptolepis sanguinolenta: an ethnobotanical approach to drug discovery and the isolation of a potentially useful new antihyperglycaemic agent.
    Luo J, Fort DM, Carlson TJ, Noamesi BK, nii-Amon-Kotei D, King SR, Tsai J, Quan J, Hobensack C, Lapresca P, Waldeck N, Mendez CD, Jolad SD, Bierer DE, Reaven GM.
    Diabet Med; 1998 May 12; 15(5):367-74. PubMed ID: 9609357
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The DNA intercalating alkaloid cryptolepine interferes with topoisomerase II and inhibits primarily DNA synthesis in B16 melanoma cells.
    Bonjean K, De Pauw-Gillet MC, Defresne MP, Colson P, Houssier C, Dassonneville L, Bailly C, Greimers R, Wright C, Quetin-Leclercq J, Tits M, Angenot L.
    Biochemistry; 1998 Apr 14; 37(15):5136-46. PubMed ID: 9548744
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Antihyperglycemic activity of compounds isolated from Indian medicinal plants.
    Akanksha, Srivastava AK, Maurya R.
    Indian J Exp Biol; 2010 Mar 14; 48(3):294-8. PubMed ID: 21046984
    [Abstract] [Full Text] [Related]

  • 15. Synthesis and antihyperglycemic evaluation of various protoberberine derivatives.
    Bian X, He L, Yang G.
    Bioorg Med Chem Lett; 2006 Mar 01; 16(5):1380-3. PubMed ID: 16359864
    [Abstract] [Full Text] [Related]

  • 16. Synthesis of some cryptolepine analogues, assessment of their antimalarial and cytotoxic activities, and consideration of their antimalarial mode of action.
    Onyeibor O, Croft SL, Dodson HI, Feiz-Haddad M, Kendrick H, Millington NJ, Parapini S, Phillips RM, Seville S, Shnyder SD, Taramelli D, Wright CW.
    J Med Chem; 2005 Apr 07; 48(7):2701-9. PubMed ID: 15801861
    [Abstract] [Full Text] [Related]

  • 17. The alpha-adrenoceptor blocking properties of cryptolepine on the rat isolated vas deferens. Studies on cryptolepine.
    Noamesi BK, Bamgbose SO.
    Planta Med; 1980 May 07; 39(1):51-6. PubMed ID: 6105685
    [No Abstract] [Full Text] [Related]

  • 18. In vitro genotoxicity of the West African anti-malarial herbal Cryptolepis sanguinolenta and its major alkaloid cryptolepine.
    Ansah C, Khan A, Gooderham NJ.
    Toxicology; 2005 Mar 01; 208(1):141-7. PubMed ID: 15664441
    [Abstract] [Full Text] [Related]

  • 19. In vitro inhibition of beta-haematin formation, DNA interactions, antiplasmodial activity, and cytotoxicity of synthetic neocryptolepine derivatives.
    Van Miert S, Jonckers T, Cimanga K, Maes L, Maes B, Lemière G, Dommisse R, Vlietinck A, Pieters L.
    Exp Parasitol; 2004 Mar 01; 108(3-4):163-8. PubMed ID: 15582513
    [Abstract] [Full Text] [Related]

  • 20. In vitro biological activities of alkaloids from Cryptolepis sanguinolenta.
    Cimanga K, De Bruyne T, Lasure A, Van Poel B, Pieters L, Claeys M, Berghe DV, Kambu K, Tona L, Vlietinck AJ.
    Planta Med; 1996 Feb 01; 62(1):22-7. PubMed ID: 8720383
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.